BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Down 43.6% in August

BlackRock Health Sciences Term Trust (NYSE:BMEZ) saw a significant drop in short interest in August. As of August 31st, there was short interest totalling 113,200 shares, a drop of 43.6% from the August 15th total of 200,800 shares. Based on an average daily volume of 240,100 shares, the short-interest ratio is currently 0.5 days.

BlackRock Health Sciences Term Trust Price Performance

Shares of NYSE:BMEZ opened at 16.05 on Friday. BlackRock Health Sciences Term Trust has a fifty-two week low of 12.93 and a fifty-two week high of 16.59. The company’s 50-day moving average is 15.79 and its 200 day moving average is 15.58.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be given a dividend of $0.176 per share. This represents a $2.11 annualized dividend and a yield of 13.16%. The ex-dividend date is Monday, September 16th.

Institutional Trading of BlackRock Health Sciences Term Trust

Several institutional investors have recently made changes to their positions in BMEZ. Private Advisor Group LLC increased its position in BlackRock Health Sciences Term Trust by 24.0% during the 4th quarter. Private Advisor Group LLC now owns 35,791 shares of the company’s stock worth $524,000 after purchasing an additional 6,935 shares in the last quarter. Oppenheimer & Co. Inc. raised its stake in shares of BlackRock Health Sciences Term Trust by 2.0% in the 4th quarter. Oppenheimer & Co. Inc. now owns 76,699 shares of the company’s stock valued at $1,124,000 after acquiring an additional 1,536 shares during the period. Chapin Davis Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 33.2% during the 1st quarter. Chapin Davis Inc. now owns 22,050 shares of the company’s stock valued at $361,000 after acquiring an additional 5,500 shares in the last quarter. Virtu Financial LLC boosted its position in BlackRock Health Sciences Term Trust by 71.2% during the 4th quarter. Virtu Financial LLC now owns 19,857 shares of the company’s stock worth $291,000 after purchasing an additional 8,256 shares during the period. Finally, Commonwealth Equity Services LLC increased its holdings in BlackRock Health Sciences Term Trust by 4.1% in the 1st quarter. Commonwealth Equity Services LLC now owns 142,038 shares of the company’s stock valued at $2,328,000 after purchasing an additional 5,537 shares in the last quarter.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.